Żółtaczka noworodkowa
Rokowania, prognozy i postęp choroby

Żółtaczka noworodkowa jest powszechnym stanem klinicznym, występującym u 60% noworodków donoszonych i 80% wcześniaków, charakteryzującym się podwyższonym poziomem bilirubiny w surowicy. Fizjologiczna żółtaczka u noworodków karmionych mlekiem modyfikowanym ustępuje zwykle w ciągu 1-2 tygodni, natomiast u dzieci karmionych piersią może utrzymywać się do 2-3 tygodni lub dłużej. Ciężka hiperbilirubinemia definiowana jest jako stężenie bilirubiny całkowitej (TSB) >20 mg/dl (342,1 μmol/l), a poziomy >30 mg/dl (513,1 μmol/l) wiążą się z ryzykiem rozwoju ostrej encefalopatii bilirubinowej (ABE) i kernicterus. Kluczowe czynniki ryzyka to wiek matki >35 lat (OR 8,8), płeć męska (OR 4,3), wcześniactwo (OR 3,9), niezgodność grup krwi ABO (OR 2,6) oraz niedobór dehydrogenazy glukozo-6-fosforanowej (G6PD). Poród przez cesarskie cięcie zmniejsza ryzyko żółtaczki o 76% w porównaniu z porodem drogami natury. Metoda Kramera do oceny wizualnej ma czułość 70,5% i swoistość 86,1%, dlatego powinna być stosowana jako test przesiewowy, a pomiar TSB w pierwszej dobie życia wraz z oceną czynników ryzyka jest niezbędny do identyfikacji noworodków zagrożonych ciężką hiperbilirubinemią.

  1. Wprowadzenie do prognozy żółtaczki noworodkowej
  2. Naturalna dynamika żółtaczki noworodkowej
  3. Czynniki ryzyka wpływające na prognozę
    1. Czynniki macierzyńskie
    2. Czynniki związane z noworodkiem
    3. Czynniki związane z porodem
  4. Metody oceny ryzyka i ich dokładność
    1. Ocena kliniczna (metoda Kramera)
    2. Ocena poziomu bilirubiny w pierwszej dobie
    3. Nowe metody nieinwazyjne
  5. Prognoza krótkoterminowa
    1. Ciężka hiperbilirubinemia
    2. Ostra encefalopatia bilirubinowa
  6. Prognoza długoterminowa
    1. Kernicterus i jego następstwa
    2. Rozwój neurologiczny
    3. Odległa zachorowalność i śmiertelność
  7. Znaczenie wczesnego wykrywania i leczenia dla prognozy
    1. Znaczenie badań przesiewowych
    2. Wpływ leczenia na prognozę
  8. Globalne aspekty prognozy żółtaczki noworodkowej
    1. Obciążenie globalne
    2. Dysproporcje w dostępie do opieki
  9. Podsumowanie czynników prognostycznych
    1. Czynniki korzystne prognostycznie
    2. Czynniki niekorzystne prognostycznie
    3. Kolejne rozdziały

Wprowadzenie do prognozy żółtaczki noworodkowej

Żółtaczka noworodkowa (neonatal jaundice) jest powszechnie występującym stanem klinicznym, charakteryzującym się żółtym zabarwieniem skóry i twardówek u noworodków spowodowanym podwyższonym poziomem bilirubiny w surowicy krwi. Do 60% noworodków urodzonych o czasie i nawet 80% wcześniaków doświadcza objawów żółtaczki w pierwszym tygodniu życia.1 Mimo powszechności tego schorzenia, jego prognoza jest zazwyczaj bardzo dobra, jeśli jest ono odpowiednio monitorowane i leczone zgodnie z przyjętymi wytycznymi.2

W większości przypadków żółtaczka noworodkowa ma charakter fizjologiczny i ustępuje samoistnie – u noworodków karmionych mlekiem modyfikowanym zazwyczaj w ciągu 2 tygodni, natomiast u dzieci karmionych piersią może utrzymywać się dłużej, nawet ponad miesiąc.3 Jednak w przypadkach ciężkiej hiperbilirubinemii niezbędna jest szybka interwencja terapeutyczna, by zapobiec potencjalnym powikłaniom neurologicznym.4

Naturalna dynamika żółtaczki noworodkowej

Typowy przebieg żółtaczki noworodkowej rozpoczyna się od pojawienia się objawów na twarzy i górnej części ciała, stopniowo rozprzestrzeniając się w kierunku palców stóp.5 U większości noworodków żółtaczka rozwija się w drugim lub trzecim dniu życia.6 Naturalny przebieg żółtaczki u zdrowych noworodków urodzonych o czasie jest zazwyczaj łagodny, a stan ustępuje bez konieczności stosowania leczenia.

W kontekście prognozy istotne są następujące prawidłowości:

  • Żółtaczka fizjologiczna u noworodków karmionych mlekiem modyfikowanym zazwyczaj ustępuje w ciągu 1-2 tygodni
  • U noworodków karmionych piersią żółtaczka może utrzymywać się dłużej, nawet 2-3 tygodnie lub więcej
  • Jeśli żółtaczka utrzymuje się powyżej 3 tygodni, wskazana jest konsultacja z lekarzem w celu wykluczenia przyczyn patologicznych7

Czynniki ryzyka wpływające na prognozę

Identyfikacja czynników ryzyka rozwoju ciężkiej hiperbilirubinemii jest kluczowa dla określenia prognozy i planowania postępowania. Badania wykazały, że na ryzyko wystąpienia i nasilenie żółtaczki noworodkowej wpływa szereg czynników:89

Czynniki macierzyńskie

Wiek matki stanowi istotny czynnik prognostyczny – prawdopodobieństwo wystąpienia żółtaczki u noworodka jest 8,8 razy wyższe u matek powyżej 35 roku życia w porównaniu do matek poniżej 25 roku życia.10 Miejsce zamieszkania również wpływa na ryzyko – mieszkańcy obszarów miejskich mają 2,4 razy większe prawdopodobieństwo rozwoju żółtaczki noworodkowej niż mieszkańcy obszarów wiejskich.11

Czynniki związane z noworodkiem

Do czynników związanych bezpośrednio z noworodkiem, które wpływają na prognozę, należą:

  • Płeć męska – noworodki płci męskiej mają 4,3 razy większe prawdopodobieństwo wystąpienia żółtaczki niż noworodki płci żeńskiej12
  • Wcześniactwo – wcześniaki mają 3,9 razy większe ryzyko rozwinięcia żółtaczki w porównaniu do noworodków urodzonych po 37. tygodniu ciąży13
  • Niezgodność grup krwi w układzie ABO – noworodki z niezgodnością ABO mają 2,6 razy większe prawdopodobieństwo wystąpienia żółtaczki14
  • Niedobór dehydrogenazy glukozo-6-fosforanowej (G6PD) – znacząco zwiększa ryzyko ciężkiej hiperbilirubinemii i kernicterus15

Czynniki związane z porodem

Sposób porodu ma znaczący wpływ na ryzyko rozwoju żółtaczki. Poród przez cesarskie cięcie okazuje się być czynnikiem ochronnym – zmniejsza ryzyko wystąpienia żółtaczki noworodkowej o 76% w porównaniu z porodem drogami natury.16

Metody oceny ryzyka i ich dokładność

Dokładna ocena ryzyka rozwoju ciężkiej hiperbilirubinemii jest istotnym elementem w przewidywaniu przebiegu żółtaczki noworodkowej i planowaniu interwencji. Stosowanych jest kilka metod oceny ryzyka o różnej skuteczności:

Ocena kliniczna (metoda Kramera)

Tradycyjna metoda wizualnej oceny żółtaczki (metoda Kramera) polega na ocenie nasilenia zażółcenia skóry i jego progresji od głowy w kierunku kończyn dolnych. Badania wykazały, że metoda ta ma:

  • Czułość: 70,5%
  • Swoistość: 86,1%
  • Dodatnia wartość predykcyjna (PPV): 89,8%
  • Ujemna wartość predykcyjna (NPV): 62,6%

Metoda Kramera może być stosowana jako test przesiewowy (dobra PPV = 89,8%), ale ze względu na niską czułość i NPV nie powinna być używana jako test potwierdzający.17

Ocena poziomu bilirubiny w pierwszej dobie

Pomiar stężenia bilirubiny całkowitej (TSB) w pierwszej dobie życia w połączeniu z indywidualną oceną czynników ryzyka stanowi wartościowe narzędzie do identyfikacji noworodków zagrożonych rozwojem znaczącej hiperbilirubinemii.18 Wczesna identyfikacja tych noworodków jest szczególnie istotna w erze wczesnych wypisów ze szpitala.

Nowe metody nieinwazyjne

Rozwijane są nowe, nieinwazyjne metody oceny ryzyka i monitorowania żółtaczki:

  • Przezskórne pomiary bilirubiny (TCB) – mimo ograniczeń, stanowią alternatywę dla inwazyjnych badań19
  • Systemy oparte na sztucznej inteligencji – nowe metody wykorzystujące głębokie uczenie osiągają dokładność do 96,87% w klasyfikowaniu stanu żółtaczki20
  • Monitorowanie wydychanego tlenku węgla (ETCOc) – pomaga w ocenie tempa produkcji bilirubiny, co jest kluczowe dla oceny ryzyka rozwoju ekstremalnej hiperbilirubinemii21

Jednoczesne wykorzystanie barw RGB i HSV w modelach AI osiąga najlepsze wyniki w przewidywaniu poziomów bilirubiny, z RMSE (średni błąd kwadratowy) na poziomie 1,13 i współczynnikiem R² równym 0,91.22 Takie innowacyjne rozwiązania mogą w przyszłości zrewolucjonizować diagnozowanie żółtaczki, szczególnie w miejscach o ograniczonych zasobach.2324

Prognoza krótkoterminowa

Krótkoterminowa prognoza dla większości noworodków z żółtaczką jest bardzo dobra. U zdrowych noworodków urodzonych o czasie, żółtaczka fizjologiczna zwykle ustępuje samoistnie, bez konieczności interwencji. Jednak w przypadku ciężkiej hiperbilirubinemii wymagane jest natychmiastowe leczenie, aby zapobiec powikłaniom neurologicznym.25

Ciężka hiperbilirubinemia

Ciężka hiperbilirubinemia, definiowana jako stężenie bilirubiny całkowitej (TSB) powyżej 20 mg/dl (342,1 μmol/l), występuje u mniej niż 2% noworodków urodzonych o czasie.26 W przypadkach bardzo wysokiego stężenia bilirubiny (>30 mg/dl lub 513,1 μmol/l), badania wykazały, że mniej niż 5% zdrowych noworodków urodzonych o czasie rozwija objawy ostrej encefalopatii bilirubinowej lub kernicterus.27

Ostra encefalopatia bilirubinowa

Ostra encefalopatia bilirubinowa (ABE) jest stanem nagłym, wymagającym natychmiastowej interwencji. Wczesne rozpoznanie i leczenie mają kluczowe znaczenie dla zapobiegania trwałym uszkodzeniom neurologicznym. Opóźnienia w rozpoznaniu i leczeniu żółtaczki są istotnym czynnikiem przyczyniającym się do rozwoju kernicterus.28

Badanie z Wielkiej Brytanii wykazało, że większość niemowląt, u których później zdiagnozowano kernicterus, została wcześniej wypisana ze szpitala, a między rozpoznaniem żółtaczki a ponownym przyjęciem do szpitala występowało opóźnienie wynoszące od 26 do 102 godzin.29

Prognoza długoterminowa

Długoterminowe rokowanie w przypadku żółtaczki noworodkowej zależy głównie od tego, czy wystąpiły powikłania neurologiczne związane z wysokim stężeniem bilirubiny. U większości noworodków z odpowiednio leczoną żółtaczką nie obserwuje się długoterminowych konsekwencji zdrowotnych.

Kernicterus i jego następstwa

Kernicterus (przewlekła encefalopatia bilirubinowa) stanowi najpoważniejsze powikłanie żółtaczki noworodkowej, jednak jego występowanie jest rzadkie – od 0,16 do 2,7 przypadków na 100 000 urodzeń w Ameryce Północnej i Europie.30 Objawy kernicterus obejmują:

  • Atetotyczne mózgowe porażenie dziecięce z niekontrolowanymi ruchami kończyn, twarzy i innych części ciała
  • Dysfunkcję słuchu i inne zaburzenia przetwarzania słuchowego
  • Dysplazję zębową
  • Porażenie spojrzenia ku górze
  • Zróżnicowany stopień niepełnosprawności intelektualnej3132

Rozwój neurologiczny

Duże prospektywne badanie kohortowe dzieci urodzonych w 35. tygodniu ciąży lub później, porównujące dzieci z poziomem TSB powyżej 13,5 mg/dl (230,9 μmol/l) z tymi o poziomie poniżej tej wartości, wykazało, że po dwóch latach obserwacji nie było istotnych różnic w częstości występowania mózgowego porażenia dziecięcego, głuchoty, opóźnienia rozwojowego lub zaburzeń wzroku.33

Jednakże w kohorcie z poziomem TSB powyżej 19 mg/dl (325,0 μmol/l) zaobserwowano zwiększone ryzyko zespołu nadpobudliwości psychoruchowej z deficytem uwagi (ADHD) – ryzyko względne = 1,9; 95% przedział ufności, 1,1 do 3,3.34

Odległa zachorowalność i śmiertelność

Zgon z powodu fizjologicznej żółtaczki noworodkowej nie powinien występować, jeśli zapewniona jest odpowiednia opieka medyczna.35 Śmiertelność związana z kernicterus może występować, szczególnie w krajach o mniej rozwiniętych systemach opieki zdrowotnej.

W badaniu przeprowadzonym w wiejskich rejonach Nigerii, 31% noworodków z kliniczną żółtaczką miało niedobór G6PD. Wśród nich 36% zmarło z powodu prawdopodobnego kernicterus, w porównaniu do zaledwie 3% noworodków z prawidłowym wynikiem badania G6PD.36

Znaczenie wczesnego wykrywania i leczenia dla prognozy

Wczesne wykrywanie i odpowiednie leczenie żółtaczki noworodkowej mają kluczowe znaczenie dla poprawy prognozy. Opóźnienia w rozpoznaniu mogą prowadzić do przedłużonej hospitalizacji, konieczności stosowania fototerapii, transfuzji krwi i poważnych powikłań, takich jak kernicterus, zaburzenia poznawcze, utrata słuchu i obniżony iloraz inteligencji.37

Znaczenie badań przesiewowych

Chociaż badania przesiewowe mogą identyfikować noworodki, u których poziom TSB prawdopodobnie przekroczy 95. percentyl, Amerykańska Grupa Zadaniowa ds. Profilaktyki (USPSTF) oraz Amerykańska Akademia Lekarzy Rodzinnych (AAFP) uznały, że istnieją niewystarczające dowody na to, że badania przesiewowe w kierunku hiperbilirubinemii są związane z poprawą wyników klinicznych.38

Wytyczne Amerykańskiej Akademii Pediatrii (AAP) dotyczące monitorowania żółtaczki noworodkowej zalecają powszechne badania przesiewowe w kierunku hiperbilirubinemii w ciągu 48 godzin od wypisu ze szpitala.39

Wpływ leczenia na prognozę

Standardowe metody leczenia żółtaczki noworodkowej obejmują:

  • Fototerapię – metoda pierwszego wyboru w leczeniu hiperbilirubinemii
  • Transfuzję wymienną – stosowaną w przypadkach ciężkiej hiperbilirubinemii, gdy fototerapia jest nieskuteczna40

Należy jednak zauważyć, że nie ma jednoznacznych dowodów na to, że fototerapia lub transfuzja wymienna zmniejszają ryzyko encefalopatii bilirubinowej.41 Niemniej jednak, stosowanie tych metod zgodnie z przyjętymi wytycznymi pozostaje standardem opieki w zapobieganiu kernicterus.

Globalne aspekty prognozy żółtaczki noworodkowej

Istnieją znaczące różnice w prognozowaniu i przebiegu żółtaczki noworodkowej między krajami o wysokim i niskim/średnim dochodzie. Ograniczone, ale przekonujące dowody wskazują, że ciężka żółtaczka noworodkowa wiąże się ze znacznym obciążeniem zdrowotnym, szczególnie w krajach o niskim i średnim dochodzie.42

Obciążenie globalne

Żółtaczka pozostaje istotną przyczyną śmiertelności noworodków na całym świecie, zajmując siódme miejsce wśród głównych przyczyn zgonów w ciągu pierwszych sześciu dni życia.43 Ostra encefalopatia bilirubinowa, transfuzje wymienne i zgony są częstymi i kosztownymi następstwami ciężkiej żółtaczki noworodkowej, szczególnie w krajach o niskim i średnim dochodzie.44

Dysproporcje w dostępie do opieki

Istnieje pilna potrzeba zajęcia się tym możliwym do zapobiegania schorzeniem w regionach o ograniczonych zasobach, zgodnie z ideą inkluzywności promowaną dla dotychczas znajdujących się w niekorzystnej sytuacji populacji w ramach obecnych Celów Zrównoważonego Rozwoju.45

Rozwój nieinwazyjnych, przystępnych cenowo i dokładnych metod oceny żółtaczki noworodkowej, takich jak aplikacje wykorzystujące sztuczną inteligencję do analizy zdjęć noworodków, może potencjalnie zrewolucjonizować diagnostykę żółtaczki noworodkowej w miejscach o ograniczonych zasobach.46

Podsumowanie czynników prognostycznych

Prognoza w przypadku żółtaczki noworodkowej zależy od wielu czynników, które można sklasyfikować jako czynniki o korzystnym i niekorzystnym wpływie na rokowanie:

Czynniki korzystne prognostycznie

  • Urodzenie o czasie (≥37 tygodni ciąży)
  • Poród przez cesarskie cięcie
  • Wiek matki poniżej 25 lat
  • Płeć żeńska noworodka
  • Brak niezgodności grupowej w układzie ABO
  • Prawidłowy poziom G6PD
  • Wczesna identyfikacja i monitorowanie poziomów bilirubiny
  • Dostęp do nowoczesnej opieki medycznej

474849

Czynniki niekorzystne prognostycznie

  • Wcześniactwo
  • Wiek matki powyżej 35 lat
  • Płeć męska noworodka
  • Niezgodność w układzie ABO
  • Niedobór G6PD
  • Opóźniona diagnoza i leczenie
  • Bardzo wysokie poziomy bilirubiny (>30 mg/dl)
  • Ograniczony dostęp do opieki medycznej

50515253

Ogólnie rzecz biorąc, prognoza dla większości noworodków z żółtaczką jest doskonała przy odpowiednim monitorowaniu i leczeniu. Jednak ze względu na potencjalne poważne następstwa nieleczonej ciężkiej hiperbilirubinemii, ważne jest, aby noworodki były dokładnie monitorowane, a te z czynnikami ryzyka lub wczesnymi oznakami znaczącej hiperbilirubinemii były szybko identyfikowane i leczone.54

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Jaundice in Newborns: Symptoms, Causes & Treatment
    https://my.clevelandclinic.org/health/diseases/22263-jaundice-in-newborns
    Jaundice in newborns is a very common condition. Up to 60% of full-term babies develop jaundice during their first week of life. As many as 80% of premature babies develop jaundice during their first week of life. […] Jaundice in newborns is normal. It usually develops by their second or third day of life. In formula-fed babies, jaundice typically goes away on its own within two weeks. In breastfed babies, jaundice can last a month or longer. […] Jaundice in newborns is common. For most babies, jaundice will get better without treatment within one to two weeks. But it’s important to have your baby’s bilirubin level checked. A high bilirubin level can lead to serious health conditions if it’s not treated immediately. These conditions include cerebral palsy, deafness and kernicterus, a type of brain damage.
  • #2 Neonatal Jaundice: Background, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/974786-overview
    Prognosis of neonatal jaundice is excellent if the patient receives treatment according to accepted guidelines. […] Brain damage due to kernicterus remains a true risk, and the apparent increased incidence of kernicterus in relatively recent years may be due to the misconception that jaundice in the healthy full-term infant is not dangerous and can be disregarded. […] In a retrospective survey from the United Kingdom, most infants who were subsequently diagnosed with kernicterus had been discharged home from the birth hospital, and there was a delay between recognition of jaundice and readmission, with a range of 26-102 hours. […] Of further note, the majority of these infants had an underlying diagnosis which raised the risk of pathologic neonatal jaundice. […] Kernicterus is the most important complication of neonatal jaundice.
  • #3 Jaundice in Newborns: Symptoms, Causes & Treatment
    https://my.clevelandclinic.org/health/diseases/22263-jaundice-in-newborns
    Jaundice in newborns is a very common condition. Up to 60% of full-term babies develop jaundice during their first week of life. As many as 80% of premature babies develop jaundice during their first week of life. […] Jaundice in newborns is normal. It usually develops by their second or third day of life. In formula-fed babies, jaundice typically goes away on its own within two weeks. In breastfed babies, jaundice can last a month or longer. […] Jaundice in newborns is common. For most babies, jaundice will get better without treatment within one to two weeks. But it’s important to have your baby’s bilirubin level checked. A high bilirubin level can lead to serious health conditions if it’s not treated immediately. These conditions include cerebral palsy, deafness and kernicterus, a type of brain damage.
  • #4 Newborn jaundice | March of Dimes
    https://www.marchofdimes.org/find-support/topics/planning-baby/newborn-jaundice
    Jaundice is a common condition in newborn babies. […] Most of the time, jaundice goes away without treatment. […] Babies who have severe jaundice must be treated quickly; otherwise, they can develop brain damage. […] But if a baby has severe jaundice and doesn’t get quick treatment, it can lead to brain damage. […] These may be warning signs of dangerously high levels of bilirubin that need quick treatment to prevent a kind of brain damage caused by high bilirubin levels (acute or chronic bilirubin encephalopathy (CBE)). […] CBE isn’t common because babies usually are treated before jaundice becomes severe. […] If untreated, CBE can cause: Athetoid cerebral palsy. Babies with this condition have uncontrollable movements in the arms, legs, face and other body parts. […] Jaundice usually clears up within 2 weeks in formula-fed babies. It may last for more than 2 to 3 weeks in breastfed babies. […] If your baby’s jaundice lasts more than 3 weeks, talk to your baby’s health care provider. […] If phototherapy doesn’t work and your baby’s bilirubin levels are still very high, your baby may need a special type of blood transfusion called an exchange transfusion.
  • #5 Artificial intelligence-based non-invasive bilirubin prediction for neonatal jaundice using 1D convolutional neural network | Scientific Reports
    https://www.nature.com/articles/s41598-025-96100-9
    Neonatal jaundice, characterized by elevated bilirubin levels causing yellow discoloration of the skin and eyes in newborns, is a critical condition requiring accurate and timely diagnosis. […] The results show that the integration of RGB and HSV color spaces yields the best performance, with an RMSE of 1.13 and an R2 score of 0.91. Moreover, the model achieved an impressive accuracy of 96.87% in classifying jaundice status into three categories. […] This study provides a promising non-invasive alternative for neonatal jaundice detection, potentially improving early diagnosis and management in clinical settings. […] The condition usually starts at the face and upper body, gradually spreading down to the toes, and is more common in premature infants. […] Recent studies highlight the critical need for accurate diagnosis and effective management of neonatal jaundice.
  • #6 Jaundice in Newborns: Symptoms, Causes & Treatment
    https://my.clevelandclinic.org/health/diseases/22263-jaundice-in-newborns
    Jaundice in newborns is a very common condition. Up to 60% of full-term babies develop jaundice during their first week of life. As many as 80% of premature babies develop jaundice during their first week of life. […] Jaundice in newborns is normal. It usually develops by their second or third day of life. In formula-fed babies, jaundice typically goes away on its own within two weeks. In breastfed babies, jaundice can last a month or longer. […] Jaundice in newborns is common. For most babies, jaundice will get better without treatment within one to two weeks. But it’s important to have your baby’s bilirubin level checked. A high bilirubin level can lead to serious health conditions if it’s not treated immediately. These conditions include cerebral palsy, deafness and kernicterus, a type of brain damage.
  • #7 Newborn jaundice | March of Dimes
    https://www.marchofdimes.org/find-support/topics/planning-baby/newborn-jaundice
    Jaundice is a common condition in newborn babies. […] Most of the time, jaundice goes away without treatment. […] Babies who have severe jaundice must be treated quickly; otherwise, they can develop brain damage. […] But if a baby has severe jaundice and doesn’t get quick treatment, it can lead to brain damage. […] These may be warning signs of dangerously high levels of bilirubin that need quick treatment to prevent a kind of brain damage caused by high bilirubin levels (acute or chronic bilirubin encephalopathy (CBE)). […] CBE isn’t common because babies usually are treated before jaundice becomes severe. […] If untreated, CBE can cause: Athetoid cerebral palsy. Babies with this condition have uncontrollable movements in the arms, legs, face and other body parts. […] Jaundice usually clears up within 2 weeks in formula-fed babies. It may last for more than 2 to 3 weeks in breastfed babies. […] If your baby’s jaundice lasts more than 3 weeks, talk to your baby’s health care provider. […] If phototherapy doesn’t work and your baby’s bilirubin levels are still very high, your baby may need a special type of blood transfusion called an exchange transfusion.
  • #8 Factors associated with neonatal jaundice among neonates admitted at referral hospitals in northeast Ethiopia: a facility-based unmatched case-control study | BMC Pregnancy and Childbirth | Full Text
    https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-024-06352-y
    Neonatal jaundice is a significant contributor to illness and death in newborns, leading to frequent admissions to neonatal intensive care units. […] The study findings revealed that maternal age over 35 years, residing in urban areas, male gender, prematurity, and ABO incompatibility were significant determinants of neonatal jaundice. […] To prevent, diagnose, and treat neonatal jaundice effectively, efforts should primarily focus on managing ABO incompatibility and early detection of prematurity. Additionally, special attention should be given to neonates born through vaginal delivery, those with mothers over 35 years old, and those residing in urban areas, as they are at higher risk of developing newborn jaundice. […] The probability of having a neonate with jaundice is 8.8 times higher for mothers older than 35 years of age compared to those younger than 25 years.
  • #9 Factors associated with neonatal jaundice among neonates admitted at referral hospitals in northeast Ethiopia: a facility-based unmatched case-control study | BMC Pregnancy and Childbirth | Full Text
    https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-024-06352-y
    Respondents who lived in urban areas were 2.4 times more likely to have neonatal jaundice than those from rural areas. […] Additionally, male neonates were found to have a 4.3 times higher likelihood of having neonatal jaundice than female neonates. […] This study showed that cesarean delivery was 76% protective of neonatal jaundice compared with vaginal delivery. […] Whereas premature neonates had a 3.9 times higher probability of having jaundice than those with gestational age greater than or equal to 37 weeks. […] Finally, neonates who had ABO incompatibility had 2.6 times more likely to have jaundice than those who had no ABO incompatibility.
  • #10 Factors associated with neonatal jaundice among neonates admitted at referral hospitals in northeast Ethiopia: a facility-based unmatched case-control study | BMC Pregnancy and Childbirth | Full Text
    https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-024-06352-y
    Neonatal jaundice is a significant contributor to illness and death in newborns, leading to frequent admissions to neonatal intensive care units. […] The study findings revealed that maternal age over 35 years, residing in urban areas, male gender, prematurity, and ABO incompatibility were significant determinants of neonatal jaundice. […] To prevent, diagnose, and treat neonatal jaundice effectively, efforts should primarily focus on managing ABO incompatibility and early detection of prematurity. Additionally, special attention should be given to neonates born through vaginal delivery, those with mothers over 35 years old, and those residing in urban areas, as they are at higher risk of developing newborn jaundice. […] The probability of having a neonate with jaundice is 8.8 times higher for mothers older than 35 years of age compared to those younger than 25 years.
  • #11 Factors associated with neonatal jaundice among neonates admitted at referral hospitals in northeast Ethiopia: a facility-based unmatched case-control study | BMC Pregnancy and Childbirth | Full Text
    https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-024-06352-y
    Respondents who lived in urban areas were 2.4 times more likely to have neonatal jaundice than those from rural areas. […] Additionally, male neonates were found to have a 4.3 times higher likelihood of having neonatal jaundice than female neonates. […] This study showed that cesarean delivery was 76% protective of neonatal jaundice compared with vaginal delivery. […] Whereas premature neonates had a 3.9 times higher probability of having jaundice than those with gestational age greater than or equal to 37 weeks. […] Finally, neonates who had ABO incompatibility had 2.6 times more likely to have jaundice than those who had no ABO incompatibility.
  • #12 Factors associated with neonatal jaundice among neonates admitted at referral hospitals in northeast Ethiopia: a facility-based unmatched case-control study | BMC Pregnancy and Childbirth | Full Text
    https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-024-06352-y
    Respondents who lived in urban areas were 2.4 times more likely to have neonatal jaundice than those from rural areas. […] Additionally, male neonates were found to have a 4.3 times higher likelihood of having neonatal jaundice than female neonates. […] This study showed that cesarean delivery was 76% protective of neonatal jaundice compared with vaginal delivery. […] Whereas premature neonates had a 3.9 times higher probability of having jaundice than those with gestational age greater than or equal to 37 weeks. […] Finally, neonates who had ABO incompatibility had 2.6 times more likely to have jaundice than those who had no ABO incompatibility.
  • #13 Factors associated with neonatal jaundice among neonates admitted at referral hospitals in northeast Ethiopia: a facility-based unmatched case-control study | BMC Pregnancy and Childbirth | Full Text
    https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-024-06352-y
    Respondents who lived in urban areas were 2.4 times more likely to have neonatal jaundice than those from rural areas. […] Additionally, male neonates were found to have a 4.3 times higher likelihood of having neonatal jaundice than female neonates. […] This study showed that cesarean delivery was 76% protective of neonatal jaundice compared with vaginal delivery. […] Whereas premature neonates had a 3.9 times higher probability of having jaundice than those with gestational age greater than or equal to 37 weeks. […] Finally, neonates who had ABO incompatibility had 2.6 times more likely to have jaundice than those who had no ABO incompatibility.
  • #14 Factors associated with neonatal jaundice among neonates admitted at referral hospitals in northeast Ethiopia: a facility-based unmatched case-control study | BMC Pregnancy and Childbirth | Full Text
    https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-024-06352-y
    Respondents who lived in urban areas were 2.4 times more likely to have neonatal jaundice than those from rural areas. […] Additionally, male neonates were found to have a 4.3 times higher likelihood of having neonatal jaundice than female neonates. […] This study showed that cesarean delivery was 76% protective of neonatal jaundice compared with vaginal delivery. […] Whereas premature neonates had a 3.9 times higher probability of having jaundice than those with gestational age greater than or equal to 37 weeks. […] Finally, neonates who had ABO incompatibility had 2.6 times more likely to have jaundice than those who had no ABO incompatibility.
  • #15 Neonatal Jaundice: Background, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/974786-overview
    The incidence of kernicterus in North America and Europe ranges from 0.16 to 2.7 cases per 100,000 births. […] Death from physiologic neonatal jaundice per se should not occur. […] Death from kernicterus may occur, particularly in countries with less developed medical care systems. […] In a study from rural Nigeria, 31% of infants with clinical jaundice tested had G6PD deficiency, 36% of these infants with G6PD deficiency died with presumed kernicterus compared with only 3% of the infants with a normal G6PD screening test result.
  • #16 Factors associated with neonatal jaundice among neonates admitted at referral hospitals in northeast Ethiopia: a facility-based unmatched case-control study | BMC Pregnancy and Childbirth | Full Text
    https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-024-06352-y
    Respondents who lived in urban areas were 2.4 times more likely to have neonatal jaundice than those from rural areas. […] Additionally, male neonates were found to have a 4.3 times higher likelihood of having neonatal jaundice than female neonates. […] This study showed that cesarean delivery was 76% protective of neonatal jaundice compared with vaginal delivery. […] Whereas premature neonates had a 3.9 times higher probability of having jaundice than those with gestational age greater than or equal to 37 weeks. […] Finally, neonates who had ABO incompatibility had 2.6 times more likely to have jaundice than those who had no ABO incompatibility.
  • #17 Reliability of visual assessment of neonatal jaundice among neonates of black descent: a cross-sectional study from Tanzania | BMC Pediatrics | Full Text
    https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-021-02859-x
    The prevalence of NJ was 49.8% by Kramers method and 63.5% by TSB. […] Kramers method had a Sensitivity-70.5%, Specificity-86.1%, PPV-89.8%, and NPV-62.6% in detecting NJ. […] Kramers method was found to have good ability of predicting presence of NJ (89.8%). […] However, due to low sensitivity and NPV one cannot say that overall predictive ability is good. […] Kramers method may be used as a predictor (PPV =89.8%) of NJ rather than confirmatory test for the presence of NJ. […] The study aimed at determining the reliability of Kramers method for assessment of NJ among neonates of black descent. […] Further studies are needed to investigate the utility of other non-invasive techniques in detecting NJ among neonates of black descent.
  • #18 Predicting the risk of jaundice in full-term healthy newborns: a prospective population-based study – PubMed
    https://pubmed.ncbi.nlm.nih.gov/10645520/
    Objective: The need to recognize infants that are at high risk for developing significant jaundice is apparent in the era of routine early discharge. The aim of the present study was to prospectively determine the ability to predict severe hyperbilirubinemia in term healthy newborns (defined as total serum bilirubin of 10.0 mg/dl at day 2, 14.0 mg/dl at day 3, and 17.0 mg/dl at days 4 and 5 of life). […] Conclusion: Individual risk assessment on discharge in association with day 1 total serum bilirubin is of value in identifying infants at greater risk for neonatal jaundice.
  • #19 Artificial intelligence-based non-invasive bilirubin prediction for neonatal jaundice using 1D convolutional neural network | Scientific Reports
    https://www.nature.com/articles/s41598-025-96100-9
    A commonly used non-invasive method involves transcutaneous bilirubin (TCB) meters. […] Despite these advantages, TCB meters have notable limitations that impact their accuracy and utility. […] Given these challenges, recent research has explored innovative solutions to improve the diagnosis and management of neonatal jaundice. […] Deep learning provides transformative potential by enabling precise and non-invasive bilirubin level estimation from neonatal images. […] This integration of advanced image processing with deep learning offers a scalable and reliable solution for early detection and management of neonatal jaundice, aiming to improve clinical outcomes while reducing dependency on invasive procedures, particularly in resource-limited settings. […] The ultimate goal is to improve early detection and management of neonatal jaundice, reducing reliance on invasive procedures and improving clinical outcomes for newborns.
  • #20 Artificial intelligence-based non-invasive bilirubin prediction for neonatal jaundice using 1D convolutional neural network | Scientific Reports
    https://www.nature.com/articles/s41598-025-96100-9
    The proposed 1DCNN achieved the highest accuracy of 96.87%, outperforming both traditional machine learning and deep learning methods. […] The study reports the lowest RMSE (1.13) and the highest R2 score (0.91) among all reviewed works, showcasing the model’s robustness and precision in predicting bilirubin levels. […] The results indicate that the RGB+HSV model achieved the lowest RMSE (1.13) and MAE (0.89), while also obtaining the highest R2 score (0.91), demonstrating that the integration of complementary color spaces enhances both precision and generalizability.
  • #21 CoSense® ETCOc Monitoring: Transformative Jaundice Management for Newborns
    https://capnia.com/bibliography
    Read the well-established and mounting body of evidence recognizing the risks of unmanaged Jaundice and supporting the use of ETCOc testing with newborns. […] More than 80% of newborn infants will have some degree of jaundice. Careful monitoring of all newborn infants and the application of appropriate treatments are essential because high bilirubin concentrations can cause acute bilirubin encephalopathy and kernicterus. […] The determination of a newborn’s bilirubin production rate is critical to the assessment of a newborn’s risk for developing unpredictable extreme HB and preventing BIND. […] The authors suggest that since unconjugated (or unbound) bilirubin increases in the presence of hemolysis, there is an association between increased bilirubin production and total body bilirubin which helps to explain the association between hemolytic jaundice and bilirubin neurotoxicity. […] The guidelines of the American Academy of Pediatrics (AAP) for monitoring neonatal jaundice recommend universal postnatal screening for hyperbilirubinemia within 48h from discharge.
  • #22 Artificial intelligence-based non-invasive bilirubin prediction for neonatal jaundice using 1D convolutional neural network | Scientific Reports
    https://www.nature.com/articles/s41598-025-96100-9
    The proposed 1DCNN achieved the highest accuracy of 96.87%, outperforming both traditional machine learning and deep learning methods. […] The study reports the lowest RMSE (1.13) and the highest R2 score (0.91) among all reviewed works, showcasing the model’s robustness and precision in predicting bilirubin levels. […] The results indicate that the RGB+HSV model achieved the lowest RMSE (1.13) and MAE (0.89), while also obtaining the highest R2 score (0.91), demonstrating that the integration of complementary color spaces enhances both precision and generalizability.
  • #23 Artificial intelligence-based non-invasive bilirubin prediction for neonatal jaundice using 1D convolutional neural network | Scientific Reports
    https://www.nature.com/articles/s41598-025-96100-9
    Neonatal jaundice, characterized by elevated bilirubin levels causing yellow discoloration of the skin and eyes in newborns, is a critical condition requiring accurate and timely diagnosis. […] The results show that the integration of RGB and HSV color spaces yields the best performance, with an RMSE of 1.13 and an R2 score of 0.91. Moreover, the model achieved an impressive accuracy of 96.87% in classifying jaundice status into three categories. […] This study provides a promising non-invasive alternative for neonatal jaundice detection, potentially improving early diagnosis and management in clinical settings. […] The condition usually starts at the face and upper body, gradually spreading down to the toes, and is more common in premature infants. […] Recent studies highlight the critical need for accurate diagnosis and effective management of neonatal jaundice.
  • #24 Real-Time Jaundice Detection in Neonates Based on Machine Learning Models
    https://www.mdpi.com/2673-7426/4/1/34
    The significance of early detection of neonatal jaundice cannot be neglected, given its potential for severe complications in infants. […] The proposed system successfully developed an application for jaundice detection using a USB-connected webcam to achieve direct real-time jaundice detection of neonates in different positions and lighting conditions rather than having images from an external source, which is time consuming and requires more effort, without the need for invasive tests. […] The proposed system extracted skin color intensities from 767 infant photos and was fed different machine learning models for testing and validation. The method demonstrated that XGBoost provided the highest achievable accuracy, at 99.63% classification, among the tested models. […] By adopting the XGBoost algorithm, future work can explore its implementation on various platforms, such as telemedicine and healthcare applications, aiming to reduce hospital visits. Thus, the proposed imaging system holds the potential to revolutionize neonatal jaundice diagnosis, providing a non-invasive and efficient solution for early detection and improved infant care.
  • #25 Neonatal Jaundice: Background, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/974786-overview
    Prognosis of neonatal jaundice is excellent if the patient receives treatment according to accepted guidelines. […] Brain damage due to kernicterus remains a true risk, and the apparent increased incidence of kernicterus in relatively recent years may be due to the misconception that jaundice in the healthy full-term infant is not dangerous and can be disregarded. […] In a retrospective survey from the United Kingdom, most infants who were subsequently diagnosed with kernicterus had been discharged home from the birth hospital, and there was a delay between recognition of jaundice and readmission, with a range of 26-102 hours. […] Of further note, the majority of these infants had an underlying diagnosis which raised the risk of pathologic neonatal jaundice. […] Kernicterus is the most important complication of neonatal jaundice.
  • #26 Evaluation and Treatment of Neonatal Hyperbilirubinemia | AAFP
    https://www.aafp.org/pubs/afp/issues/2014/0601/p873.html
    Although neonatal jaundice is common, acute bilirubin encephalopathy and kernicterus (i.e., chronic bilirubin encephalopathy) are rare. […] Severe hyperbilirubinemia (total serum bilirubin [TSB] level of more than 20 mg per dL [342.1 mol per L]) occurs in less than 2% of term infants and can lead to kernicterus (i.e., chronic bilirubin encephalopathy) and permanent neurodevelopmental delay. […] Kernicterus develops in one in 100,000 infants and manifests as athetoid cerebral palsy, auditory dysfunction, dental dysplasia, paralysis of upward gaze, and variable intellectual disability. […] One study found that less than 5% of healthy term infants with a TSB level greater than 30 mg per dL (513.1 mol per L) developed acute bilirubin encephalopathy or kernicterus. […] Although screening can identify infants whose TSB level will likely exceed the 95th percentile, the U.S. Preventive Services Task Force and the American Academy of Family Physicians found insufficient evidence that screening for hyperbilirubinemia is associated with improved clinical outcomes.
  • #27 Evaluation and Treatment of Neonatal Hyperbilirubinemia | AAFP
    https://www.aafp.org/pubs/afp/issues/2014/0601/p873.html
    Although neonatal jaundice is common, acute bilirubin encephalopathy and kernicterus (i.e., chronic bilirubin encephalopathy) are rare. […] Severe hyperbilirubinemia (total serum bilirubin [TSB] level of more than 20 mg per dL [342.1 mol per L]) occurs in less than 2% of term infants and can lead to kernicterus (i.e., chronic bilirubin encephalopathy) and permanent neurodevelopmental delay. […] Kernicterus develops in one in 100,000 infants and manifests as athetoid cerebral palsy, auditory dysfunction, dental dysplasia, paralysis of upward gaze, and variable intellectual disability. […] One study found that less than 5% of healthy term infants with a TSB level greater than 30 mg per dL (513.1 mol per L) developed acute bilirubin encephalopathy or kernicterus. […] Although screening can identify infants whose TSB level will likely exceed the 95th percentile, the U.S. Preventive Services Task Force and the American Academy of Family Physicians found insufficient evidence that screening for hyperbilirubinemia is associated with improved clinical outcomes.
  • #28 Neonatal Jaundice: Background, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/974786-overview
    Prognosis of neonatal jaundice is excellent if the patient receives treatment according to accepted guidelines. […] Brain damage due to kernicterus remains a true risk, and the apparent increased incidence of kernicterus in relatively recent years may be due to the misconception that jaundice in the healthy full-term infant is not dangerous and can be disregarded. […] In a retrospective survey from the United Kingdom, most infants who were subsequently diagnosed with kernicterus had been discharged home from the birth hospital, and there was a delay between recognition of jaundice and readmission, with a range of 26-102 hours. […] Of further note, the majority of these infants had an underlying diagnosis which raised the risk of pathologic neonatal jaundice. […] Kernicterus is the most important complication of neonatal jaundice.
  • #29 Neonatal Jaundice: Background, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/974786-overview
    Prognosis of neonatal jaundice is excellent if the patient receives treatment according to accepted guidelines. […] Brain damage due to kernicterus remains a true risk, and the apparent increased incidence of kernicterus in relatively recent years may be due to the misconception that jaundice in the healthy full-term infant is not dangerous and can be disregarded. […] In a retrospective survey from the United Kingdom, most infants who were subsequently diagnosed with kernicterus had been discharged home from the birth hospital, and there was a delay between recognition of jaundice and readmission, with a range of 26-102 hours. […] Of further note, the majority of these infants had an underlying diagnosis which raised the risk of pathologic neonatal jaundice. […] Kernicterus is the most important complication of neonatal jaundice.
  • #30 Neonatal Jaundice: Background, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/974786-overview
    The incidence of kernicterus in North America and Europe ranges from 0.16 to 2.7 cases per 100,000 births. […] Death from physiologic neonatal jaundice per se should not occur. […] Death from kernicterus may occur, particularly in countries with less developed medical care systems. […] In a study from rural Nigeria, 31% of infants with clinical jaundice tested had G6PD deficiency, 36% of these infants with G6PD deficiency died with presumed kernicterus compared with only 3% of the infants with a normal G6PD screening test result.
  • #31 Evaluation and Treatment of Neonatal Hyperbilirubinemia | AAFP
    https://www.aafp.org/pubs/afp/issues/2014/0601/p873.html
    Although neonatal jaundice is common, acute bilirubin encephalopathy and kernicterus (i.e., chronic bilirubin encephalopathy) are rare. […] Severe hyperbilirubinemia (total serum bilirubin [TSB] level of more than 20 mg per dL [342.1 mol per L]) occurs in less than 2% of term infants and can lead to kernicterus (i.e., chronic bilirubin encephalopathy) and permanent neurodevelopmental delay. […] Kernicterus develops in one in 100,000 infants and manifests as athetoid cerebral palsy, auditory dysfunction, dental dysplasia, paralysis of upward gaze, and variable intellectual disability. […] One study found that less than 5% of healthy term infants with a TSB level greater than 30 mg per dL (513.1 mol per L) developed acute bilirubin encephalopathy or kernicterus. […] Although screening can identify infants whose TSB level will likely exceed the 95th percentile, the U.S. Preventive Services Task Force and the American Academy of Family Physicians found insufficient evidence that screening for hyperbilirubinemia is associated with improved clinical outcomes.
  • #32 Newborn jaundice | March of Dimes
    https://www.marchofdimes.org/find-support/topics/planning-baby/newborn-jaundice
    Jaundice is a common condition in newborn babies. […] Most of the time, jaundice goes away without treatment. […] Babies who have severe jaundice must be treated quickly; otherwise, they can develop brain damage. […] But if a baby has severe jaundice and doesn’t get quick treatment, it can lead to brain damage. […] These may be warning signs of dangerously high levels of bilirubin that need quick treatment to prevent a kind of brain damage caused by high bilirubin levels (acute or chronic bilirubin encephalopathy (CBE)). […] CBE isn’t common because babies usually are treated before jaundice becomes severe. […] If untreated, CBE can cause: Athetoid cerebral palsy. Babies with this condition have uncontrollable movements in the arms, legs, face and other body parts. […] Jaundice usually clears up within 2 weeks in formula-fed babies. It may last for more than 2 to 3 weeks in breastfed babies. […] If your baby’s jaundice lasts more than 3 weeks, talk to your baby’s health care provider. […] If phototherapy doesn’t work and your baby’s bilirubin levels are still very high, your baby may need a special type of blood transfusion called an exchange transfusion.
  • #33 Evaluation and Treatment of Neonatal Hyperbilirubinemia | AAFP
    https://www.aafp.org/pubs/afp/issues/2014/0601/p873.html
    Screening will identify infants earlier who require phototherapy, but there is no evidence that phototherapy or exchange transfusion decreases the risk of bilirubin encephalopathy. […] A large prospective cohort study of children delivered at 35 weeks’ gestation or later compared those with TSB levels greater than 13.5 mg per dL (230.9 mol per L) with those who have levels less than 13.5 mg per dL. […] At two years’ follow-up, there were no significant differences in rates of cerebral palsy, deafness, developmental delay, or visual abnormalities. […] The cohort with TSB levels greater than 19 mg per dL (325.0 mol per L) had an increased risk of attention deficit disorder (relative risk = 1.9; 95% confidence interval, 1.1 to 3.3).
  • #34 Evaluation and Treatment of Neonatal Hyperbilirubinemia | AAFP
    https://www.aafp.org/pubs/afp/issues/2014/0601/p873.html
    Screening will identify infants earlier who require phototherapy, but there is no evidence that phototherapy or exchange transfusion decreases the risk of bilirubin encephalopathy. […] A large prospective cohort study of children delivered at 35 weeks’ gestation or later compared those with TSB levels greater than 13.5 mg per dL (230.9 mol per L) with those who have levels less than 13.5 mg per dL. […] At two years’ follow-up, there were no significant differences in rates of cerebral palsy, deafness, developmental delay, or visual abnormalities. […] The cohort with TSB levels greater than 19 mg per dL (325.0 mol per L) had an increased risk of attention deficit disorder (relative risk = 1.9; 95% confidence interval, 1.1 to 3.3).
  • #35 Neonatal Jaundice: Background, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/974786-overview
    The incidence of kernicterus in North America and Europe ranges from 0.16 to 2.7 cases per 100,000 births. […] Death from physiologic neonatal jaundice per se should not occur. […] Death from kernicterus may occur, particularly in countries with less developed medical care systems. […] In a study from rural Nigeria, 31% of infants with clinical jaundice tested had G6PD deficiency, 36% of these infants with G6PD deficiency died with presumed kernicterus compared with only 3% of the infants with a normal G6PD screening test result.
  • #36 Neonatal Jaundice: Background, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/974786-overview
    The incidence of kernicterus in North America and Europe ranges from 0.16 to 2.7 cases per 100,000 births. […] Death from physiologic neonatal jaundice per se should not occur. […] Death from kernicterus may occur, particularly in countries with less developed medical care systems. […] In a study from rural Nigeria, 31% of infants with clinical jaundice tested had G6PD deficiency, 36% of these infants with G6PD deficiency died with presumed kernicterus compared with only 3% of the infants with a normal G6PD screening test result.
  • #37 Artificial intelligence-based non-invasive bilirubin prediction for neonatal jaundice using 1D convolutional neural network | Scientific Reports
    https://www.nature.com/articles/s41598-025-96100-9
    Timely detection is crucial to avoid severe and potentially life-threatening complications. […] Jaundice remains a significant cause of neonatal mortality worldwide, ranking seventh in the leading causes of death within the first six days of life. […] This delay may lead to prolonged hospital stays, phototherapy, blood transfusions, and severe complications such as kernicterus, cognitive impairments, hearing loss, and reduced IQ. […] The diagnosis of neonatal jaundice is predominantly conducted in hospitals and clinics through the measurement of total serum bilirubin (TSB) obtained from a blood sample. […] However, its invasive nature presents significant challenges, particularly for newborns. […] These drawbacks highlight the need for less invasive and more accessible diagnostic alternatives.
  • #38 Evaluation and Treatment of Neonatal Hyperbilirubinemia | AAFP
    https://www.aafp.org/pubs/afp/issues/2014/0601/p873.html
    Although neonatal jaundice is common, acute bilirubin encephalopathy and kernicterus (i.e., chronic bilirubin encephalopathy) are rare. […] Severe hyperbilirubinemia (total serum bilirubin [TSB] level of more than 20 mg per dL [342.1 mol per L]) occurs in less than 2% of term infants and can lead to kernicterus (i.e., chronic bilirubin encephalopathy) and permanent neurodevelopmental delay. […] Kernicterus develops in one in 100,000 infants and manifests as athetoid cerebral palsy, auditory dysfunction, dental dysplasia, paralysis of upward gaze, and variable intellectual disability. […] One study found that less than 5% of healthy term infants with a TSB level greater than 30 mg per dL (513.1 mol per L) developed acute bilirubin encephalopathy or kernicterus. […] Although screening can identify infants whose TSB level will likely exceed the 95th percentile, the U.S. Preventive Services Task Force and the American Academy of Family Physicians found insufficient evidence that screening for hyperbilirubinemia is associated with improved clinical outcomes.
  • #39 CoSense® ETCOc Monitoring: Transformative Jaundice Management for Newborns
    https://capnia.com/bibliography
    Read the well-established and mounting body of evidence recognizing the risks of unmanaged Jaundice and supporting the use of ETCOc testing with newborns. […] More than 80% of newborn infants will have some degree of jaundice. Careful monitoring of all newborn infants and the application of appropriate treatments are essential because high bilirubin concentrations can cause acute bilirubin encephalopathy and kernicterus. […] The determination of a newborn’s bilirubin production rate is critical to the assessment of a newborn’s risk for developing unpredictable extreme HB and preventing BIND. […] The authors suggest that since unconjugated (or unbound) bilirubin increases in the presence of hemolysis, there is an association between increased bilirubin production and total body bilirubin which helps to explain the association between hemolytic jaundice and bilirubin neurotoxicity. […] The guidelines of the American Academy of Pediatrics (AAP) for monitoring neonatal jaundice recommend universal postnatal screening for hyperbilirubinemia within 48h from discharge.
  • #40 Newborn jaundice | March of Dimes
    https://www.marchofdimes.org/find-support/topics/planning-baby/newborn-jaundice
    Jaundice is a common condition in newborn babies. […] Most of the time, jaundice goes away without treatment. […] Babies who have severe jaundice must be treated quickly; otherwise, they can develop brain damage. […] But if a baby has severe jaundice and doesn’t get quick treatment, it can lead to brain damage. […] These may be warning signs of dangerously high levels of bilirubin that need quick treatment to prevent a kind of brain damage caused by high bilirubin levels (acute or chronic bilirubin encephalopathy (CBE)). […] CBE isn’t common because babies usually are treated before jaundice becomes severe. […] If untreated, CBE can cause: Athetoid cerebral palsy. Babies with this condition have uncontrollable movements in the arms, legs, face and other body parts. […] Jaundice usually clears up within 2 weeks in formula-fed babies. It may last for more than 2 to 3 weeks in breastfed babies. […] If your baby’s jaundice lasts more than 3 weeks, talk to your baby’s health care provider. […] If phototherapy doesn’t work and your baby’s bilirubin levels are still very high, your baby may need a special type of blood transfusion called an exchange transfusion.
  • #41 Evaluation and Treatment of Neonatal Hyperbilirubinemia | AAFP
    https://www.aafp.org/pubs/afp/issues/2014/0601/p873.html
    Screening will identify infants earlier who require phototherapy, but there is no evidence that phototherapy or exchange transfusion decreases the risk of bilirubin encephalopathy. […] A large prospective cohort study of children delivered at 35 weeks’ gestation or later compared those with TSB levels greater than 13.5 mg per dL (230.9 mol per L) with those who have levels less than 13.5 mg per dL. […] At two years’ follow-up, there were no significant differences in rates of cerebral palsy, deafness, developmental delay, or visual abnormalities. […] The cohort with TSB levels greater than 19 mg per dL (325.0 mol per L) had an increased risk of attention deficit disorder (relative risk = 1.9; 95% confidence interval, 1.1 to 3.3).
  • #42 Burden of severe neonatal jaundice: a systematic review and meta-analysis
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5862199/
    To assess the global burden of late and/or poor management of severe neonatal jaundice (SNJ), a common problem worldwide, which may result in death or irreversible brain damage with disabilities in survivors. […] Limited but compelling evidence demonstrates that SNJ is associated with a significant health burden especially in low-income and middle-income countries. […] Acute bilirubin encephalopathy (ABE), exchange transfusions and death are frequent and costly outcomes of severe neonatal jaundice (SNJ) especially in low-income and middle-income countries. […] Current evidence indicates SNJ continues to contribute significantly to the burden of cerebral palsy, deafness and other auditory processing disorders. […] Compelling but limited evidence from the literature demonstrates that SNJ is associated with a significant acute and chronic health burden, especially in LMICs. There is an urgent need to address this preventable disease in these regions, consistent with the inclusiveness advocated for erstwhile disadvantaged populations under the current SDGs dispensation.
  • #43 Artificial intelligence-based non-invasive bilirubin prediction for neonatal jaundice using 1D convolutional neural network | Scientific Reports
    https://www.nature.com/articles/s41598-025-96100-9
    Timely detection is crucial to avoid severe and potentially life-threatening complications. […] Jaundice remains a significant cause of neonatal mortality worldwide, ranking seventh in the leading causes of death within the first six days of life. […] This delay may lead to prolonged hospital stays, phototherapy, blood transfusions, and severe complications such as kernicterus, cognitive impairments, hearing loss, and reduced IQ. […] The diagnosis of neonatal jaundice is predominantly conducted in hospitals and clinics through the measurement of total serum bilirubin (TSB) obtained from a blood sample. […] However, its invasive nature presents significant challenges, particularly for newborns. […] These drawbacks highlight the need for less invasive and more accessible diagnostic alternatives.
  • #44 Burden of severe neonatal jaundice: a systematic review and meta-analysis
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5862199/
    To assess the global burden of late and/or poor management of severe neonatal jaundice (SNJ), a common problem worldwide, which may result in death or irreversible brain damage with disabilities in survivors. […] Limited but compelling evidence demonstrates that SNJ is associated with a significant health burden especially in low-income and middle-income countries. […] Acute bilirubin encephalopathy (ABE), exchange transfusions and death are frequent and costly outcomes of severe neonatal jaundice (SNJ) especially in low-income and middle-income countries. […] Current evidence indicates SNJ continues to contribute significantly to the burden of cerebral palsy, deafness and other auditory processing disorders. […] Compelling but limited evidence from the literature demonstrates that SNJ is associated with a significant acute and chronic health burden, especially in LMICs. There is an urgent need to address this preventable disease in these regions, consistent with the inclusiveness advocated for erstwhile disadvantaged populations under the current SDGs dispensation.
  • #45 Burden of severe neonatal jaundice: a systematic review and meta-analysis
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5862199/
    To assess the global burden of late and/or poor management of severe neonatal jaundice (SNJ), a common problem worldwide, which may result in death or irreversible brain damage with disabilities in survivors. […] Limited but compelling evidence demonstrates that SNJ is associated with a significant health burden especially in low-income and middle-income countries. […] Acute bilirubin encephalopathy (ABE), exchange transfusions and death are frequent and costly outcomes of severe neonatal jaundice (SNJ) especially in low-income and middle-income countries. […] Current evidence indicates SNJ continues to contribute significantly to the burden of cerebral palsy, deafness and other auditory processing disorders. […] Compelling but limited evidence from the literature demonstrates that SNJ is associated with a significant acute and chronic health burden, especially in LMICs. There is an urgent need to address this preventable disease in these regions, consistent with the inclusiveness advocated for erstwhile disadvantaged populations under the current SDGs dispensation.
  • #46 Real-Time Jaundice Detection in Neonates Based on Machine Learning Models
    https://www.mdpi.com/2673-7426/4/1/34
    The significance of early detection of neonatal jaundice cannot be neglected, given its potential for severe complications in infants. […] The proposed system successfully developed an application for jaundice detection using a USB-connected webcam to achieve direct real-time jaundice detection of neonates in different positions and lighting conditions rather than having images from an external source, which is time consuming and requires more effort, without the need for invasive tests. […] The proposed system extracted skin color intensities from 767 infant photos and was fed different machine learning models for testing and validation. The method demonstrated that XGBoost provided the highest achievable accuracy, at 99.63% classification, among the tested models. […] By adopting the XGBoost algorithm, future work can explore its implementation on various platforms, such as telemedicine and healthcare applications, aiming to reduce hospital visits. Thus, the proposed imaging system holds the potential to revolutionize neonatal jaundice diagnosis, providing a non-invasive and efficient solution for early detection and improved infant care.
  • #47 Factors associated with neonatal jaundice among neonates admitted at referral hospitals in northeast Ethiopia: a facility-based unmatched case-control study | BMC Pregnancy and Childbirth | Full Text
    https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-024-06352-y
    Neonatal jaundice is a significant contributor to illness and death in newborns, leading to frequent admissions to neonatal intensive care units. […] The study findings revealed that maternal age over 35 years, residing in urban areas, male gender, prematurity, and ABO incompatibility were significant determinants of neonatal jaundice. […] To prevent, diagnose, and treat neonatal jaundice effectively, efforts should primarily focus on managing ABO incompatibility and early detection of prematurity. Additionally, special attention should be given to neonates born through vaginal delivery, those with mothers over 35 years old, and those residing in urban areas, as they are at higher risk of developing newborn jaundice. […] The probability of having a neonate with jaundice is 8.8 times higher for mothers older than 35 years of age compared to those younger than 25 years.
  • #48 Factors associated with neonatal jaundice among neonates admitted at referral hospitals in northeast Ethiopia: a facility-based unmatched case-control study | BMC Pregnancy and Childbirth | Full Text
    https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-024-06352-y
    Respondents who lived in urban areas were 2.4 times more likely to have neonatal jaundice than those from rural areas. […] Additionally, male neonates were found to have a 4.3 times higher likelihood of having neonatal jaundice than female neonates. […] This study showed that cesarean delivery was 76% protective of neonatal jaundice compared with vaginal delivery. […] Whereas premature neonates had a 3.9 times higher probability of having jaundice than those with gestational age greater than or equal to 37 weeks. […] Finally, neonates who had ABO incompatibility had 2.6 times more likely to have jaundice than those who had no ABO incompatibility.
  • #49 Neonatal Jaundice: Background, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/974786-overview
    The incidence of kernicterus in North America and Europe ranges from 0.16 to 2.7 cases per 100,000 births. […] Death from physiologic neonatal jaundice per se should not occur. […] Death from kernicterus may occur, particularly in countries with less developed medical care systems. […] In a study from rural Nigeria, 31% of infants with clinical jaundice tested had G6PD deficiency, 36% of these infants with G6PD deficiency died with presumed kernicterus compared with only 3% of the infants with a normal G6PD screening test result.
  • #50 Factors associated with neonatal jaundice among neonates admitted at referral hospitals in northeast Ethiopia: a facility-based unmatched case-control study | BMC Pregnancy and Childbirth | Full Text
    https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-024-06352-y
    Neonatal jaundice is a significant contributor to illness and death in newborns, leading to frequent admissions to neonatal intensive care units. […] The study findings revealed that maternal age over 35 years, residing in urban areas, male gender, prematurity, and ABO incompatibility were significant determinants of neonatal jaundice. […] To prevent, diagnose, and treat neonatal jaundice effectively, efforts should primarily focus on managing ABO incompatibility and early detection of prematurity. Additionally, special attention should be given to neonates born through vaginal delivery, those with mothers over 35 years old, and those residing in urban areas, as they are at higher risk of developing newborn jaundice. […] The probability of having a neonate with jaundice is 8.8 times higher for mothers older than 35 years of age compared to those younger than 25 years.
  • #51 Factors associated with neonatal jaundice among neonates admitted at referral hospitals in northeast Ethiopia: a facility-based unmatched case-control study | BMC Pregnancy and Childbirth | Full Text
    https://bmcpregnancychildbirth.biomedcentral.com/articles/10.1186/s12884-024-06352-y
    Respondents who lived in urban areas were 2.4 times more likely to have neonatal jaundice than those from rural areas. […] Additionally, male neonates were found to have a 4.3 times higher likelihood of having neonatal jaundice than female neonates. […] This study showed that cesarean delivery was 76% protective of neonatal jaundice compared with vaginal delivery. […] Whereas premature neonates had a 3.9 times higher probability of having jaundice than those with gestational age greater than or equal to 37 weeks. […] Finally, neonates who had ABO incompatibility had 2.6 times more likely to have jaundice than those who had no ABO incompatibility.
  • #52 Neonatal Jaundice: Background, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/974786-overview
    Prognosis of neonatal jaundice is excellent if the patient receives treatment according to accepted guidelines. […] Brain damage due to kernicterus remains a true risk, and the apparent increased incidence of kernicterus in relatively recent years may be due to the misconception that jaundice in the healthy full-term infant is not dangerous and can be disregarded. […] In a retrospective survey from the United Kingdom, most infants who were subsequently diagnosed with kernicterus had been discharged home from the birth hospital, and there was a delay between recognition of jaundice and readmission, with a range of 26-102 hours. […] Of further note, the majority of these infants had an underlying diagnosis which raised the risk of pathologic neonatal jaundice. […] Kernicterus is the most important complication of neonatal jaundice.
  • #53 Neonatal Jaundice: Background, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/974786-overview
    The incidence of kernicterus in North America and Europe ranges from 0.16 to 2.7 cases per 100,000 births. […] Death from physiologic neonatal jaundice per se should not occur. […] Death from kernicterus may occur, particularly in countries with less developed medical care systems. […] In a study from rural Nigeria, 31% of infants with clinical jaundice tested had G6PD deficiency, 36% of these infants with G6PD deficiency died with presumed kernicterus compared with only 3% of the infants with a normal G6PD screening test result.
  • #54 Neonatal Jaundice: Background, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/974786-overview
    Prognosis of neonatal jaundice is excellent if the patient receives treatment according to accepted guidelines. […] Brain damage due to kernicterus remains a true risk, and the apparent increased incidence of kernicterus in relatively recent years may be due to the misconception that jaundice in the healthy full-term infant is not dangerous and can be disregarded. […] In a retrospective survey from the United Kingdom, most infants who were subsequently diagnosed with kernicterus had been discharged home from the birth hospital, and there was a delay between recognition of jaundice and readmission, with a range of 26-102 hours. […] Of further note, the majority of these infants had an underlying diagnosis which raised the risk of pathologic neonatal jaundice. […] Kernicterus is the most important complication of neonatal jaundice.

Zobacz więcej

niedobór dehydrogenazy glukozo-6-fosforanowej fototerapia powikłanie neurologiczne bilirubina całkowita encefalopatia bilirubinowa kernicterus cesarskie cięcie wcześniak zespół nadpobudliwości psychoruchowej z deficytem uwagi mózgowe porażenie dziecięce żółtaczka noworodkowa metoda Kramera niezgodność grup krwi ABO dehydrogenaza glukozo-6-fosforanowa przezskórny pomiar bilirubiny żółtaczka fizjologiczna hiperbilirubinemia ostra encefalopatia bilirubinowa transfuzja wymienna